Search for Clinical Trial Results
Chronic Inflammatory Demyelinating Polyneuropathy - 26 Studies Found
Status | Study |
Completed |
Study Name: Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Condition:
Date: 1999-11-03 Interventions: Drug: intravenous immunoglobulin (IVIg) |
Completed |
Study Name: Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Date: 2005-09-13 Interventions:
|
Terminated |
Study Name: Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2010-10-06 Interventions:
|
Withdrawn |
Study Name: Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) Condition: Chronic Inflammatory Demyelinating Neuropathy Date: 2012-12-06 Interventions: Drug: Alemtuzumab infusion |
Recruiting |
Study Name: Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Condition: CIDP Date: 2015-12-10 Interventions: Other: CIDP treated (IVIG) usual treatment with intravenous immunoglobulin |
RECRUITING |
Study Name: Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients Condition: Pediatric Chronic Inflammatory Demyelinating Polyneuropathy Date: 2024-05-18 Interventions: PANZYGA is a human immunoglobin solution with 10% protein content for intravenous (IV) administration. |